JELD‑WEN to cut 850 jobs and trims 2025 outlook after deep Q3 loss; Europe business under strategic review

JELD‑WEN to cut 850 jobs and trims 2025 outlook after deep Q3 loss; Europe business under strategic review

Date: Nov. 6, 2025

Key takeaways

  • Door-and-window maker JELD‑WEN (NYSE: JELD) will eliminate ~850 roles (about 11% of its North America and corporate workforce) by year‑end 2025. [1]
  • Q3 2025 results: revenue $809.5M (‑13.4% YoY); net loss $367.6M (including a non‑cash goodwill impairment). Adjusted EBITDA $44.4M (5.5% margin). [2]
  • Company lowered full‑year 2025 guidance to $3.1B–$3.2B revenue and $105M–$120M adjusted EBITDA; expects ~$10M–$20M in workforce‑reduction costs and ~$45M operating cash outflow for the year. [3]
  • Local impact: cuts include roles in Charlotte, where JELD‑WEN is headquartered. [4]
  • Market reaction: shares fell after the announcement as investors digested the reduced outlook and job cuts. [5]

What’s new today (Nov. 6)

Following Monday’s earnings release, JELD‑WEN confirmed it will shed ~850 positions across North America and corporate functions and is reviewing strategic alternatives for its Europe segment. The workforce actions, slated to be completed by the end of 2025, are part of a broader cost‑reset amid weaker demand and price‑cost pressure. [6]

Charlotte’s local press reports the reductions will include positions in the Charlotte area, adding a regional dimension to the restructuring at the company’s headquarters. [7]


The numbers: Q3 at a glance

  • Revenue:$809.5M (‑13.4% YoY), driven by a 10% decline in core revenue and the impact of the Towanda divestiture (‑5%), partially offset by +2% FX.
  • Net loss:$367.6M (‑$4.30/share), reflecting a $196.9M non‑cash goodwill impairment and $122.3M in tax special items.
  • Adjusted EBITDA:$44.4M, margin 5.5% (down 320 bps YoY).
  • Segment detail:North America revenue $546.1M (‑19.4%) on softer volume/mix; Europe revenue $263.3M (+2.6%) on favorable FX despite softer core demand. [8]

The Associated Press likewise summarized the quarter as a loss‑making period with revenue at $809.5M and a net loss translating to ‑$4.30 per share. [9]


Guidance cut and cash outlook

Management lowered 2025 guidance to $3.1B–$3.2B revenue (core down 10%–13% YoY) and $105M–$120M adjusted EBITDA, citing a competitive pricing and volume environment. JELD‑WEN now expects an operating cash outflow of ~$45M in 2025, including $10M–$20M of workforce‑reduction costs. [10]


Strategy reset: Europe under review

As part of the transformation plan, the company initiated a strategic review of its Europe business—a portfolio move that could include divestiture, partnerships or other alternatives, according to the company’s release. [11]


How Wall Street is reacting

JELD‑WEN shares fell after the update as investors weighed job cuts, a lower outlook and the Europe review. Financial press coverage flagged the stock’s weakness on the news. [12]


Analyst context: a painful present, potential for a multi‑year turnaround

Equity research aggregators note a tough five‑year stretch—losses have grown ~78% annually—but also point to consensus models that project a sharp EPS rebound (~131% CAGR) over the next few years as cost actions flow through, even with only modest revenue growth. That optimistic scenario hinges on execution of the transformation and stabilization of end‑market demand. [13]


What it means for employees and the Carolinas

  • Who’s affected: approximately 850 positions across North America and corporate teams, with roles in Charlotte among those impacted. The company says decisions are designed to “align cost structure” and “improve efficiency.” [14]
  • Timing & costs: actions are targeted for completion by year‑end 2025; the company estimates $10M–$20M in related costs this year. [15]

The road ahead: 5 things to watch

  1. Restructuring execution: cadence of severance, footprint changes, SKU rationalization and procurement savings versus guidance. [16]
  2. Europe review outcome: potential sale or partnership could reshape the portfolio and balance sheet. [17]
  3. North America demand: management cited weaker volume/mix; any turn in housing activity or repair‑and‑remodel could help margins. [18]
  4. Margins vs. pricing: price‑cost dynamics remain a headwind; watch the adjusted EBITDA margin trajectory from 5.5%. [19]
  5. Capital and cash: management’s ~$45M operating cash use guidance and any deleveraging or asset‑sale proceeds. [20]

Quick Q&A

Why is JELD‑WEN cutting jobs now?
Management says the reductions are needed to rebalance costs amid weaker demand and to support a multi‑year transformation, while it also reviews Europe for strategic options. [21]

How severe was Q3?
Revenue fell 13.4%, and the company posted a $367.6M net loss driven largely by a non‑cash goodwill impairment; adjusted EBITDA margin slid to 5.5%. [22]

Will Charlotte be affected?
Yes—the Charlotte Observer reports the cuts will include roles in Charlotte, where JELD‑WEN is headquartered. [23]

What’s the 2025 outlook now?
Revenue $3.1B–$3.2B, adjusted EBITDA $105M–$120M; operating cash flow expected to be ~$45M use, including $10M–$20M in workforce‑reduction costs. [24]

What are analysts modeling long‑term?
Some forecast a triple‑digit EPS growth rate over coming years if the turnaround sticks, but risks remain if volumes and pricing don’t stabilize. [25]


Sources

  • JELD‑WEN Q3 2025 news release and fact sheet (financials, guidance, restructuring). [26]
  • Charlotte Observer: local impact and Charlotte roles included in the headcount reduction. [27]
  • AP earnings snapshot for confirmation of revenue and per‑share loss. [28]
  • Barron’s/MarketWatch: coverage of stock reaction to the announcement. [29]
  • Simply Wall St: multi‑year loss trend and consensus turnaround forecasts. [30]

This article is intended for general news purposes and does not constitute investment advice.

References

1. s2.q4cdn.com, 2. s2.q4cdn.com, 3. s2.q4cdn.com, 4. www.charlotteobserver.com, 5. www.barrons.com, 6. s2.q4cdn.com, 7. www.charlotteobserver.com, 8. s2.q4cdn.com, 9. www.greenwichtime.com, 10. s2.q4cdn.com, 11. investors.jeld-wen.com, 12. www.barrons.com, 13. simplywall.st, 14. s2.q4cdn.com, 15. s2.q4cdn.com, 16. s2.q4cdn.com, 17. investors.jeld-wen.com, 18. s2.q4cdn.com, 19. s2.q4cdn.com, 20. s2.q4cdn.com, 21. s2.q4cdn.com, 22. s2.q4cdn.com, 23. www.charlotteobserver.com, 24. s2.q4cdn.com, 25. simplywall.st, 26. s2.q4cdn.com, 27. www.charlotteobserver.com, 28. www.greenwichtime.com, 29. www.barrons.com, 30. simplywall.st

Stock Market Today

  • Johnson Controls Clears Avg 12-Month Target at $74.69; Shares Trade at $76.41
    November 6, 2025, 9:12 AM EST. Johnson Controls International plc (JCI) shares traded at $76.41, above the average 12-month target price of $74.69. The pull comes amid 13 Zacks-covered targets, ranging from $51.00 to $87.00, with a standard deviation of $13.60. This reflects a wisdom of crowds view. The breakdown shows Strong Buy and Buy ratings totaling 8 versus Hold 5, with an average rating of 1.81. The move prompts investors to decide whether to push the target higher or take chips off the table. Data from Zacks Investment Research via Quandl.com.
  • AMGN Crosses Above Average Analyst Target, Trading Near $241
    November 6, 2025, 9:04 AM EST. AMGN traded at $241.01, topping the average analyst target price of $239.88 from 16 Zacks-covered targets. The move above the target could prompt analysts to re-price higher or adjust more modestly, depending on future fundamentals. The target set spans from a low of $194.00 to a high of $298.00, with a standard deviation of $29.323, underscoring divergent views. The piece invokes the wisdom of crowds idea behind the target and notes the current mix: Strong Buy (5), Hold (12), Strong Sell (1), with an overall average rating of 2.56 on a 1-5 scale. Source: Zacks Investment Research via Quandl.com.
  • Acushnet Holdings Stock (GOLF) Trades Above 12-Month Target Amid Analyst Divergence
    November 6, 2025, 9:00 AM EST. Shares of Acushnet Holdings Corp (GOLF) moved to $66.96, topping the consensus 12-month target of $65.33. With nine targets contributing to the average, the range runs from a low $58 to a high $84 and a standard deviation of $8.79, underscoring differing views among analysts. Crossing the target can prompt a re-rating: either a downgrade or a higher hurdle for peers. The piece notes the 'wisdom of crowds' behind the target and asks investors whether $65.33 is a stepping stone to a higher objective or a sign of overvaluation. Analysts' ratings show mostly Hold with a few Buys, and a final average rating of about 2.3 on a 1-5 scale.
  • Stagwell Reports Q3 2025 Results: Revenue Growth, Palantir Partnership, and 2025 Guidance
    November 6, 2025, 8:55 AM EST. Stagwell Inc. (STGW) posted Q3 2025 results with Q3 Revenue of $743 million, up 4% YoY, and Net Revenue of $615 million, up 6%. Excluding Advocacy, Q3 Revenue rose 12% to $686 million. Q3 Net Income attributable to common shareholders was $25 million; EPS $0.09; Adjusted EPS $0.24. Adjusted EBITDA was $115 million (3% YoY), with YTD Adjusted EBITDA of $288 million. Net New Business added $122 million in Q3 (LTM $472 million). The company also announced a Palantir partnership. For 2025, management guides Total Net Revenue growth ~8%, Adjusted EBITDA $410-$460 million, and Free Cash Flow Conversion >45%.
  • Oscar Health (OSCR) Q3 2025 Earnings Preview: What To Look For
    November 6, 2025, 8:52 AM EST. OSCR investors are eyeing Oscar Health's Q3 2025 results due Nov 6. Street consensus calls for revenue of $3.08B and EPS of -$0.61, with the full-year outlook at $12.04B revenue and - $1.41 per share. Over the last 90 days, revenue estimates rose to $12.04B (2025) and $11.34B (2026) while earnings expectations declined to - $1.41 (2025) and - $0.47 (2026). In the prior quarter, actual revenue was $2.86B vs $2.89B expected, and earnings were - $0.89 vs - $0.46 expected. The stock traded higher ~3.8% after the last report. Analysts' price targets average $13.18 (range $8-$19.95), implying a potential downside to the current price of about 23%, though GuruFocus GF Value hints at an upside of 1.46% to $17.41. The consensus rating is Hold (3.3/5).
Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call
Previous Story

Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call

Morocco’s €3.7bn produce surge and blueberry boom; Qatar’s Qatari Diar unveils $29.7bn Egypt coast megaproject — Nov 6, 2025
Next Story

Morocco’s €3.7bn produce surge and blueberry boom; Qatar’s Qatari Diar unveils $29.7bn Egypt coast megaproject — Nov 6, 2025

Go toTop